Gemcitabine Plus Bevacizumab in Locally Recurrent or Metastatic Breast Cancer
Clinical trial NCT00623233 · COMPLETED
Trial details
- NCT number
- NCT00623233
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2011-01-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.